The Role of Vitamin D Supplementation on Well Being and Symptoms of Depression During the Winter Season in Health Service Staff

NCT01462058 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2012-03-29

No results posted yet for this study

Summary

The purpose of this study is to investigate whether vitamin D3 (70 micrograms) is better than placebo in preventing depression symptoms among employees in health care

Conditions

  • Seasonal Affective Disorder
  • Vitamin D3
  • Mental Health
  • Dietary Supplement

Interventions

DIETARY_SUPPLEMENT

Vitamin D3

70µg Vitamin D3, daily, 12 weeks

DRUG

Placebo

Placebo, daily, 12 weeks

Sponsors & Collaborators

  • Connie Thuree Nielsen, consultant, MD, ph.d

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01462058 on ClinicalTrials.gov